dipyridamole has been researched along with Idiopathic Parkinson Disease in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole (DIP) was tested for its ability to induce dopaminergic (DA) phenotype in cultures from epidermal growth factor-derived mesencephalic precursor cells." | 1.31 | Dipyridamole-induced increase in production of rat dopaminergic neurons from mesencephalic precursors. ( Caruncho, HJ; Guerra, MJ; Labandeira-García, JL; Rodríguez-Pallares, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodríguez-Pallares, J | 1 |
| Caruncho, HJ | 1 |
| Guerra, MJ | 1 |
| Labandeira-García, JL | 1 |
| Danta, G | 1 |
2 other studies available for dipyridamole and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Dipyridamole-induced increase in production of rat dopaminergic neurons from mesencephalic precursors.
Topics: Animals; Brain Tissue Transplantation; Cell Differentiation; Cell Size; Cells, Cultured; Dipyridamol | 2002 |
Second phase platelet aggregation induced by adenosine diphosphate in patients with cerebral vascular disease and in control subjects.
Topics: Adenine Nucleotides; Adult; Aged; Blood Platelets; Bronchitis; Carpal Tunnel Syndrome; Cerebrovascul | 1970 |